BB
BB Biotech Portfolio holdings
AUM
$3.98B
This Quarter Return
-16.82%
1 Year Return
+15.06%
3 Year Return
+120.36%
5 Year Return
+263.74%
10 Year Return
–
AUM
$3.12B
AUM Growth
+$3.12B
(-17%)
Cap. Flow
+$70.8M
Cap. Flow
% of AUM
2.27%
Top 10 Holdings %
Top 10 Hldgs %
64.02%
Holding
36
New
4
Increased
20
Reduced
3
Closed
2
Top Buys
| 1 |
Moderna
MRNA
|
$73.1M |
| 2 |
Agios Pharmaceuticals
AGIO
|
$31.4M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
$29.1M |
| 4 |
Scholar Rock
SRRK
|
$25M |
| 5 |
Kezar Life Sciences
KZR
|
$19.3M |
Top Sells
| 1 |
TSRO
TESARO, Inc.
TSRO
|
$114M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$49.2M |
| 3 |
CELG
Celgene Corp
CELG
|
$43.6M |
| 4 |
Gilead Sciences
GILD
|
$38.9M |
| 5 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$4.71M |
Sector Composition
| 1 | Healthcare | 96.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Voyager Therapeutics
VYGR
$204M
| $26.9M | 0.86% |
2,865,841
+43,200
| +2% | +$406K |
|
|
27
Regeneron Pharmaceuticals
REGN
$59.8B
| $25.5M | 0.82% |
68,156
-131,844
| -66% | -$49.2M |
|
|
ITCI
28
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $25.1M | 0.8% |
2,200,000
| – | – |
|
|
29
Kezar Life Sciences
KZR
$28.5M
| $19.3M | 0.62% |
+818,432
| New | +$19.3M |
|
|
BOLD
30
DELISTED
Audentes Therapeutics, Inc
BOLD
| $16.4M | 0.53% |
+769,404
| New | +$16.4M |
|
31
Sangamo Therapeutics
SGMO
$161M
| $15.5M | 0.5% |
+1,350,000
| New | +$15.5M |
|
32
Novavax
NVAX
$1.2B
| $15.3M | 0.49% |
8,330,000
| – | – |
|
|
GTHX
33
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $12.9M | 0.41% |
671,925
+246,607
| +58% | +$4.72M |
|
34
Cidara Therapeutics
CDTX
$1.61B
| $5.39M | 0.17% |
2,295,272
| – | – |
|
|
ACHN
35
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| – | – |
-1,279,340
| Closed | -$4.71M |
|
|
TSRO
36
DELISTED
TESARO, Inc.
TSRO
| – | – |
-2,931,802
| Closed | -$114M |
|